Global Report

February 2010
Pharmaceutical Representative;Feb2010, Vol. 40 Issue 2, p10
The article offers news briefs related to the pharmaceutical industry including the antitrust investigation by the European Commission (EC) on Danish drug company Lundbeck, Great Britain's move to recoup some of the 500 million pounds it spent on the H1N1 vaccine, and the World Health Organization's (WHO) estimate that fraud and abuse in medical care cost governments 23 billion dollars yearly.


Related Articles

  • The Value of Innovation.  // Health Affairs;Sep/Oct2001, Vol. 20 Issue 5, p10 

    Focuses on the concerns over pharmaceutical profits and the effect of technology on health care costs in the United States. Criticisms on the pharmaceutical industry by media, citizens and the Congress; Details on the technological changes in medical conditions; Assessment on the benefits of...

  • Government plans to curb drug spending.  // Life Science Today;Apr2001, Vol. 2 Issue 2, p6 

    Reports on the French government's efforts to deal with drug spending that has hit an all time high in 2000.

  • Matters of (Re) Import. Clinton, Patrick // Pharmaceutical Executive;Sep2003, Vol. 23 Issue 9, p14 

    Focuses on the safety of products in the pharmaceutical industry in the U.S. Discussions on the changes in healthcare; Key to controlling healthcare costs; Services of pharmacies.

  • Shape Up! Scheinkopf, Lisa // Pharmaceutical Executive;Oct2002, Vol. 22 Issue 10, p92 

    Determines the creation of fitness program in pharmaceutical companies in the U.S. Increase of healthcare costs in the industry; Problems associated with public health crisis; Establishment of direct-to-consumer brand awareness activity.

  • Transferring the financial risks of pharmaceutical benefits from a large health care provider in Argentina to a consortium of pharmaceutical companies. Cervellino, Juan C.; Corazza, Sandra B.; Bignone, Ines M. I.; Fligman, M. Diana; Figueroa, Silvana; Roldan, Ruben; Morici, Pablo; Diez, Roberto A. // Revista Panamericana de Salud Publica;Apr2003, Vol. 13 Issue 4, p203 

    Presents a study which examined the decision of the National Institute of Social Services for Retirees and Pensioners in Argentina to transfer the risk for the cost of outpatient medications and cancer treatment drugs to a consortium of pharmaceutical companies in exchange for a fixed monthly...

  • AstraZeneca Is Subject of EU Antitrust Probe.  // Chemical Market Reporter;8/11/2003, Vol. 264 Issue 4, p12 

    Reports on the antitrust investigation against AstraZeneca PLC by the European Commission alleging the company for delaying generic entrants of its gastrointestinal drug Prilosec/Losec in Europe. Details on the abusive practices of the company; Disclosure on sales generated by the drug;...

  • Generic medicine a 'sweeter' pill to swallow.  // Finance Week;9/14/2001, p44 

    Focuses the use of generic medicines for the reduction of the cost of medical care in South Africa. Impact of the allotted budget of the government on ethical and generic medicine price; Differential spending of the government on ethical and generic medicines; Beneficial influence of generic...

  • Report finds Rx spending will double in five years. Levy, Sandra // Drug Topics;6/18/2001, Vol. 145 Issue 12, p16 

    Forecasts that the 2001 prescription drug spending in the United States will double over the next five years. Chronic health conditions among middle-age people; Factors responsible for the growth in drug spending; Categories that represent more than half of the increase in costs.

  • Policymakers eye increased prescription drug spending, PBM promotional activities. Wechsler, Jill // Formulary;Nov98, Vol. 33 Issue 11, p1147 

    Reports that United States policy makers are eyeing increased prescription drug spending and pharmacy benefit management promotional activities in light of the rising health care spending. Prediction for a major surge in health care spending; Congress' concern that developments are affecting...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics